FDA Grants Orphan Drug Designation to Omeros’ OMS721 for Treatment of IgA Nephropathy
Go back to FDA Grants Orphan Drug Designation to Omeros’ OMS721 for Treatment of IgA Nephropathy| Omeros Corporation (NASDAQ: OMER) | Delayed: 18.95 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.95 | 52 Week High | $16.80 | |||
| Open | $18.95 | 52 Week Low | $7.20 | |||
| Day High | $18.95 | P/E | N/A | |||
| Day Low | $18.95 | EPS | $-1.64 | |||
| Volume | 1,849 | |||||
